From the Lab: Vibe Coding with Replit

I don’t always start with Figma. Sometimes I start with a feeling. A layout. A friction point. A hunch.

That’s when I go to Replit and start vibe coding.


What is Vibe Coding?

It’s not engineering. It’s not design. It’s fast prototyping at the idea level.

Vibe coding is how I think through interaction, flow, and feasibility before I’ve settled on what it should look like. It’s how I test ideas, not polish them. I don’t care about the font or the button radius. I care if the concept moves, responds, or simplifies the problem.


Why Replit?

Replit gives me speed.

  • I can upload a sketch and ask it to build something functional
  • I can describe a feature and let it try
  • I can simplify in loops: try, break, try again

It won’t replicate your UI exactly. It tends to follow its own design language. But it respects structure. It follows flow. And when it drifts, you just ask it to correct course.

I’ve used it to:

  • Build GPT-like tools
  • Connect APIs
  • Run small internal apps
  • Prototype early versions of healthcare tools
  • Store and test data models
  • Explore features we haven’t pitched yet

It lets me pressure-test ideas without a full build or UI pass.

Article content

What Makes It Useful

Sometimes I use Replit like a sketchbook. Other times like a lab. If I’m blocked, it gives me motion. If I’m deep in complexity, it gives me simplification.

You don’t need to overthink structure or performance. You’re not designing a final product. You’re solving for experience, and the tool helps you do that by generating a working prototype fast.


Where It Fits in My Process

Once I get a layout or interaction that works, I move on:

  • Figma, for design
  • Components, for scale
  • Systems, for consistency

But now I’m designing something I’ve already tested. I’m not guessing. I’m shaping.

Vibe coding is not the final step. It’s the one that saves you from wasting time on ideas that don’t land.

Article content

Why Share This?

Because too many people jump into design tools without testing their logic. Because wireframes should work, not just look good. Because discovery matters more than decoration.

If you’re stuck, open Replit. Let it try. Let it miss. Then shape what comes back.

That’s the vibe.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More